Evidence map›Paper›PMID 28657497›Full record

ArticleRedox report : communications in free radical research2017

Hesperidin attenuates inflammation and oxidative damage in pleural exudates and liver of rat model of pleurisy.

Stephen Adeniyi Adefegha, Daniela Bitencourt Rosa Leal, Ayodeji Augustine Olabiyi, Ganiyu Oboh, Livia Gelain Castilhos

Open access · goldAbstract read
In one paragraph

Article in Redox report : communications in free radical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Stephen Adeniyi Adefeghaa Department of Biochemistry , Functional Food and Nutraceutical Unit, Federal University of Technology , Akure , Nigeria.
Daniela Bitencourt Rosa Lealb Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria , Santa Maria , Brazil.
Ayodeji Augustine Olabiyia Department of Biochemistry , Functional Food and Nutraceutical Unit, Federal University of Technology , Akure , Nigeria.
Ganiyu Oboha Department of Biochemistry , Functional Food and Nutraceutical Unit, Federal University of Technology , Akure , Nigeria.
Livia Gelain Castilhosc Departamento de Microbiologia e Parasitologia , Centro de Ciências da Saúde, Universidade Federal de Santa Maria , Santa Maria , Brazil.
Universidade Federal de Santa Maria · BRFederal University of Technology · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study investigated the potential anti-inflammatory effect of hesperidin against carrageenan induced pleurisy in rat model.

methodsTwenty-four adult female Wistar rats (350 - 450g) were grouped as follows: Group I: rats were administered saline solution only (Normal control group); Group II: rats were administered saline solution (NaCl 0.9%) orally and injected with carrageenan (Inflammation control group); Group III: rats were administered hesperidin only (Hesperidin group); Group IV: rats were administered hesperidin orally and intrapleurally injected with 2% carrageenan (Inflammation treated with hesperidin group). The exudate volume, total leukocyte count, reactive oxygen species (ROS), myeloperoxidase (MPO),δ-aminolevulinate dehydratase (δ-ALA-D), catalase (CAT), superoxide dismutase (SOD), activities as well as non-protein thiol group (NPSH) and thiobarbituric acid reactive substances (TBARS) levels were determined.

resultsPretreatment with hesperidin at a dose of 80 mg/kg orally per day for 21 days, minimized the increase in pleural exudate volume and leucocyte count and modulated the activities of MPO, SOD and CAT, as well as the levels of ROS, NPSH and TBARS in carrageenan-induced rats.

conclusionOur results suggest that hesperidin can elicit its anti-inflammatory action by blocking exudate and leukocyte influx into pleural cavity, inhibiting MPO activity and preventing oxidative damage.

Indexed as

AnimalsAnti-Inflammatory AgentsCatalaseGlutathioneHesperidinInflammationLiverOxidative StressPeroxidasePleurisyPorphobilinogen SynthaseRatsRats, WistarReactive Oxygen SpeciesSuperoxide DismutaseThiobarbituric Acid Reactive SubstancesAnti-Inflammatory AgentsCatalaseGlutathioneHesperidinPeroxidasePorphobilinogen SynthaseReactive Oxygen SpeciesSuperoxide DismutaseThiobarbituric Acid Reactive Substancesantioxidant enzymescarrageenanHesperidininflammationpleural exudate

Identifiers

PMID28657497
PMCPMC8900622
OpenAlexW2726218530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.